Previsioni di mercato degli adiuvanti per vaccini in Medio Oriente e Africa fino al 2030 – Analisi regionale – per classe di adiuvanti (adiuvante di sale minerale, adiuvante di emulsione, adiuvante di liposomi e altri) e tipo (adiuvante di vaccino umano e adiuvante di vaccino veterinario)
I progressi tecnologici rafforzano il mercato degli adiuvanti per vaccini in Medio Oriente e Africa
Attualmente, gli adiuvanti a base di sale di alluminio o gel sono utilizzati prevalentemente nei vaccini autorizzati. L\'adiuvante monofosforil lipide A (MPL) e i copolimeri idrofobici sono esempi di questi componenti. Le microsfere idrofobiche pongono sfide durante la produzione del vaccino. I problemi includono molti problemi di smaltimento dei rifiuti e contaminazione ambientale e sono dispendiosi in termini di tempo, costosi e inefficienti. Pertanto, i produttori stanno enfatizzando lo sviluppo di nuove tecnologie per evitare l\'uso di solventi organici. Ad esempio, la tecnologia degli adiuvanti per vaccini di Aphios comprende la nanotecnologia e la sua produzione include fluidi supercritici, critici o quasi critici con o senza cosolventi polari come l\'etanolo [denominati superfluidi (SFS)]. I biopolimeri biodegradabili vengono disciolti in SFS e miscelati con vaccini subunitari in una soluzione acquosa o come una sospensione di nanoparticelle. Pertanto, tali nuove tecnologie degli adiuvanti per vaccini vengono sviluppate per realizzare nanosfere polimeriche biodegradabili (PNS) attraverso nuovi processi, che consentono ai produttori di vaccini di escludere l\'uso di solventi organici. Pertanto, i progressi tecnologici porteranno probabilmente nuove tendenze nel mercato degli adiuvanti per vaccini nei prossimi anni.
Panoramica del mercato degli adiuvanti per vaccini in Medio Oriente e Africa
Il mercato degli adiuvanti per vaccini in Medio Oriente e Africa è stato segmentato in Arabia Saudita, Sudafrica, Emirati Arabi Uniti e resto del Medio Oriente e Africa. Un aumento delle approvazioni di prodotto è un fattore importante per la crescita positiva del mercato degli adiuvanti per vaccini in Arabia Saudita. Le approvazioni di prodotto da parte della SAFDA aumenteranno l\'adozione di vaccini adiuvati e ne accelereranno l\'adozione nei prossimi anni in Arabia Saudita, spingendo la crescita del mercato dal 2020 al 2030.
Ricavi e previsioni del mercato degli adiuvanti per vaccini in Medio Oriente e Africa fino al 2030 (milioni di $ USA)
Segmentazione del mercato degli adiuvanti per vaccini in Medio Oriente e Africa
Il mercato degli adiuvanti per vaccini in Medio Oriente e Africa è categorizzato in classe, tipo e paese di adiuvanti.
In base alla classe di adiuvanti, il mercato degli adiuvanti per vaccini in Medio Oriente e Africa è segmentato in adiuvante di sali minerali, adiuvante di emulsione, adiuvante di liposomi e altri. Il segmento degli adiuvanti dei sali minerali ha detenuto la quota maggiore del mercato degli adiuvanti dei vaccini in Medio Oriente e Africa nel 2022.
Per tipologia, il mercato degli adiuvanti dei vaccini in Medio Oriente e Africa è diviso in adiuvanti dei vaccini umani e adiuvanti dei vaccini veterinari. Il segmento degli adiuvanti dei vaccini umani ha detenuto una quota maggiore del mercato degli adiuvanti dei vaccini in Medio Oriente e Africa nel 2022.
Per paese, il mercato degli adiuvanti dei vaccini in Medio Oriente e Africa è suddiviso in Arabia Saudita, Sudafrica, Emirati Arabi Uniti e resto del Medio Oriente e Africa. L\'Arabia Saudita ha dominato la quota di mercato degli adiuvanti dei vaccini in Medio Oriente e Africa nel 2022.
Croda International Plc; CSL Ltd; GSK Plc; Novavax Inc; e Phibro Animal Health Corp sono alcune delle aziende leader che operano nel mercato degli adiuvanti dei vaccini in Medio Oriente e Africa.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Vaccine Adjuvants Market – Key Market Dynamics
4.1 Middle East & Africa Vaccine Adjuvants Market – Key Market Dynamics
4.2 Market Drivers
4.2.1 Rising Number of Infectious Disease Outbreaks and Pandemic
4.2.2 Approvals of Veterinary Vaccine Adjuvants
4.3 Market Restraints
4.3.1 Product Recalls and Adverse Effects
4.4 Market Opportunities
4.4.1 Advancements in Biotechnology and Immunology
4.5 Future Trends
4.5.1 Technological Advancements
4.6 Impact of Drivers and Restraints:
5. Vaccine Adjuvants Market –Middle East & Africa Market Analysis
5.1 Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
5.2 Middle East & Africa Vaccine Adjuvants Market Forecast and Analysis
6. Middle East & Africa Vaccine Adjuvants Market Analysis –by Adjuvant Class
6.1 Overview
6.2 Mineral Salt Adjuvant
6.2.1 Overview
6.2.2 Mineral Salt Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
6.3 Emulsion Adjuvant
6.3.1 Overview
6.3.2 Emulsion Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Liposome Adjuvant
6.4.1 Overview
6.4.2 Liposome Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Others
6.5.1 Overview
6.5.2 Others: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa Vaccine Adjuvants Market Analysis – by Type
7.1 Human Vaccine Adjuvant
7.1.1 Overview
7.1.2 Human Vaccine Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
7.2 Veterinary Vaccine Adjuvant
7.2.1 Overview
7.2.2 Veterinary Vaccine Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Vaccine Adjuvants Market –Country Analysis
8.1 Middle East & Africa
8.1.1 Middle East & Africa: Vaccine Adjuvants Market – Revenue and Forecast Analysis – by Country
8.1.1.1 Saudi Arabia: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.1.1 Overview
8.1.1.1.2 Saudi Arabia: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.1.3 Saudi Arabia: Vaccine Adjuvants Market Breakdown, by Adjuvant Class
8.1.1.1.4 Saudi Arabia: Vaccine Adjuvants Market Breakdown, by Type
8.1.1.2 South Africa: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.2.1 Overview
8.1.1.2.2 South Africa: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.2.3 South Africa: Vaccine Adjuvants Market Breakdown, by Adjuvant Class
8.1.1.2.4 South Africa: Vaccine Adjuvants Market Breakdown, by Type
8.1.1.3 United Arab Emirates: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.3.1 Overview
8.1.1.3.2 United Arab Emirates: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.3.3 United Arab Emirates: Vaccine Adjuvants Market Breakdown, by Adjuvant Class
8.1.1.3.4 United Arab Emirates: Vaccine Adjuvants Market Breakdown, by Type
8.1.1.4 Rest of Middle East and Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.4.1 Overview
8.1.1.4.2 Rest of Middle East and Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.4.3 Rest of Middle East and Africa Vaccine Adjuvants Market Breakdown, by Adjuvant Class
8.1.1.4.4 Rest of Middle East and Africa Vaccine Adjuvants Market Breakdown, by Type
9. Industry Landscape
9.1 Overview
9.2 Growth Strategies in the Global Vaccine Adjuvants Market
9.3 Organic Developments
9.3.1 Overview
9.4 Inorganic Developments
9.4.1 Overview
10. Company Profiles
10.1 GSK Plc
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 CSL Ltd
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Croda International Plc
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Novavax Inc
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Phibro Animal Health Corp
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
11. Appendix
11.1 About The Insight Partners
List of Tables
Table 1. Middle East & Africa Vaccine Adjuvants Market Segmentation
Table 2. Middle East & Africa Vaccine Adjuvants Market Revenue and Forecasts To 2030 (US$ Million)
Table 3. Saudi Arabia: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class
Table 4. Saudi Arabia: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 5. South Africa: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class
Table 6. South Africa: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 7. United Arab Emirates: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class
Table 8. United Arab Emirates: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 9. Rest of Middle East and Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class
Table 10. Rest of Middle East and Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 11. Organic Developments Done by Companies
Table 12. Inorganic Developments Done by Companies
List of Figures
Figure 1. Middle East & Africa Vaccine Adjuvants Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Middle East & Africa Vaccine Adjuvants Market Revenue (US$ Million), 2022–2030
Figure 4. Middle East & Africa Vaccine Adjuvants Market Share (%) – by Adjuvant Class (2022 and 2030)
Figure 5. Mineral Salt Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 6. Emulsion Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Liposome Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Middle East & Africa Vaccine Adjuvants Market Share (%) – by Type (2022 and 2030)
Figure 10. Human Vaccine Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Veterinary Vaccine Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Middle East and Africa Vaccine Adjuvants Market by Key Countries – Revenue 2022 (US$ Million)
Figure 13. Middle East and Africa Vaccine Adjuvants Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 14. Saudi Arabia: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)
Figure 15. South Africa: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)
Figure 16. United Arab Emirates: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)
Figure 17. Rest of Middle East and Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)
Figure 18. Growth Strategies in the Vaccine Adjuvants Market
- Croda International Plc
- CSL Ltd
- GSK Plc
- Novavax Inc
- Phibro Animal Health Corp
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa vaccine adjuvants market.
- Highlights key business priorities to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa vaccine adjuvants market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa vaccine adjuvants market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.